New proton beam study aims to cut cancer treatment side effects
NCT ID NCT07601672
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests proton beam therapy for stage II seminoma, a testicular cancer that is highly curable. The goal is to see if this more targeted radiation can treat the cancer effectively while reducing long-term side effects and the risk of developing another cancer later in life. About 20 men will take part to measure treatment safety and quality of life.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SEMINOMA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- High-Dose chemo with stem cell transplant tested against standard therapy for tough germ cell cancers
- Testicular cancer treatment: which is easier on patients?
- Testicular cancer patients needed for landmark treatment reduction study
- Blood marker may predict cancer return in testicular tumor patients
- Immunotherapy duo takes on resistant germ cell tumors
- Can less be more? new trial aims to reduce side effects in testicular cancer treatment